Align Technology Inc
Company Profile
Business description
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Contact
410 North Scottsdale Road
Suite 1300
TempeAZ85288
USAT: +1 602 742-2000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2024
Employees
21,690
Align Technology Inc News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,427.60 | 110.90 | 1.33% |
CAC 40 | 7,274.48 | 19.89 | -0.27% |
DAX 40 | 19,884.75 | 85.11 | -0.43% |
Dow JONES (US) | 42,840.26 | 498.02 | 1.18% |
FTSE 100 | 8,084.61 | 20.71 | -0.26% |
HKSE | 19,857.98 | 137.28 | 0.70% |
NASDAQ | 19,572.60 | 199.83 | 1.03% |
Nikkei 225 | 39,052.10 | 350.20 | 0.90% |
NZX 50 Index | 12,988.03 | 83.92 | 0.65% |
S&P 500 | 5,930.85 | 63.77 | 1.09% |
S&P/ASX 200 | 8,176.90 | 109.90 | 1.36% |
SSE Composite Index | 3,374.99 | 6.92 | 0.21% |